We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
Cap. Flow
+$552M
Cap. Flow %
5.91%
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$39.4M
3
INTC icon
Intel
INTC
+$29.2M
4
QCOM icon
Qualcomm
QCOM
+$27.6M
5
DHR icon
Danaher
DHR
+$26M

Top Sells

Rank Stock Value
1
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$49.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$41.6M
3
ARQL
Arqule Inc
ARQL
+$26.5M
4
ARWR icon
Arrowhead Research
ARWR
+$24.9M
5
MRK icon
Merck
MRK
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 19.55%
3 Financials 10.18%
4 Consumer Discretionary 9.32%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
426
Madrigal Pharmaceuticals
MDGL
$12.7B
$3.73M 0.04%
40,950
-500
-1% -$48.5K
DGX icon
427
Quest Diagnostics
DGX
$25.6B
$3.66M 0.04%
34,280
+6,863
+25% +$716K
OGS icon
428
ONE Gas
OGS
$5.02B
$3.62M 0.04%
38,687
-4,852
-11% -$444K
ALLY icon
429
Ally Financial
ALLY
$13.3B
– –
-54,274
Closed -$1.69M
PRNB
430
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
– –
0
– –
SPPI
431
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$3.61M 0.04%
990,882
-26,518
-3% -$214K
AFL icon
432
Aflac
AFL
$64.4B
$3.6M 0.04%
68,092
-2,432
-3% -$129K
GBT
433
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.58M 0.04%
+45,000
New +$2.67M
SJM icon
434
J.M. Smucker
SJM
$12.9B
$3.57M 0.04%
34,301
-8,916
-21% -$944K
MELI icon
435
Mercado Libre
MELI
$92.3B
$3.55M 0.04%
6,202
-8,069
-57% -$4.47M
WU icon
436
Western Union
WU
$2.55B
$3.55M 0.04%
132,428
+84,803
+178% +$2.2M
CPRT icon
437
Copart
CPRT
$27.6B
$3.5M 0.04%
153,964
+101,024
+191% +$2.16M
RSG icon
438
Republic Services
RSG
$66.7B
$3.5M 0.04%
29,140
-2,368
-8% -$207K
TU icon
439
Telus
TU
$16.2B
$3.5M 0.04%
180,298
+832
+0.5% +$15.4K
XIFR
440
XPLR Infrastructure LP
XIFR
$1.19B
$3.49M 0.04%
66,309
+56,899
+605% +$2.96M
RVNC
441
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.49M 0.04%
215,000
-22,000
-9% -$341K
BBD icon
442
Banco Bradesco
BBD
$38.5B
$3.49M 0.04%
518,756
+124,232
+31% +$778K
STT icon
443
State Street
STT
$50.7B
$3.48M 0.04%
44,026
-2,742
-6% -$193K
EXPE icon
444
Expedia Group
EXPE
$33.4B
$3.44M 0.04%
31,846
+17,726
+126% +$2.08M
UAL icon
445
United Airlines
UAL
$39.1B
$3.44M 0.04%
39,027
-49,304
-56% -$4.43M
AVB icon
446
AvalonBay Communities
AVB
$26.8B
$3.44M 0.04%
16,387
+853
+5% +$183K
ACAD icon
447
Acadia Pharmaceuticals
ACAD
$4.35B
$3.42M 0.04%
+80,000
New +$3.48M
MRVL icon
448
Marvell Technology
MRVL
$170B
$3.35M 0.04%
126,092
+88,904
+239% +$2.25M
TREX icon
449
Trex
TREX
$4.57B
$3.35M 0.04%
74,458
-146,372
-66% -$6.45M
HPQ icon
450
HP
HPQ
$24.3B
$3.33M 0.04%
161,935
-25,985
-14% -$492K
16 17
18
19 20

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2019 Portfolio in Review

As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.

  • Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
  • Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
  • Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
  • Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
  • Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
  • Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.

Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.